“Changes in the Concentration of EGFR-Mutated Plasma DNA in the First Hours of Anti-EGFR Therapy Allow the Prediction of Tumor Response in Patients With EGFR-Driven Lung Cancer”. Voprosy Onkologii, vol. 67, no. 5, Oct. 2021, pp. 665-74, https://doi.org/10.37469/0507-3758-2021-67-5-665-674.